Annual Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN)

19–21 September 2019 • Magdeburg, Germany


Print-File

Congress details

Downloads

Online Programm

Transparency

The member companies of the "Voluntary Self-Regulation of the Pharmaceutical Industry (FSA) eV" have more narrowly defined the FSA code to ensure more transparency. 

In future, congress organisers are obliged to inform potential congress participants, in advance, about the scope and terms of the support of the pharmaceutical industry. We fulfil this obligation and therefore inform you about the amount of the sponsorship of companies involved:

  • Agilent Technologies Sales and Services (Industrial exhibition, 1,500 EUR)
  • Celgene GmbH (Main sponsoring, 3,000 EUR)
  • Illumina GmbH (Industrial symposium, 1,000 EUR)
  • Novartis Pharma GmbH (Main sponsoring, 3,000 EUR)
  • Novocure GmbH (Main sponsoring, 3,000 EUR)
  • Roche Pharma AG (Industrial exhibition, 1,500 EUR)
  • Sanofi-Aventis Deutschland GmbH (Main sponsoring, 3,000 EUR)
  • teva GmbH (Financial sponsoring, 2,500 EUR)
  • Epredia (Industrial exhibition, 1,500 EUR)
  • ZEISS (Main sponsoring, 3,000 EUR)